Breast MRI with PET Screening, Mammography Correlation and the Economics of Breast MR

Apr 5th, 2006Apr 7th, 2006
Chicago, IL
US
https://www.proscan.com/fw/main/2006_Breast_v2-495.html
Participants will explore the economics and reimbursement of breast MRI by drawing on Dr. Pomeranz's 17 years of experience siting and benchmarking over 50 magnets in centers, including a women's imaging center.
Latest in Home
(A) Ga-68 NK224 PET/CT maximum intensity projection image (left), axial PET/CT images (center), and axial CT images (right) in a 43-year-old female participant with lung adenocarcinoma show lesions in the right cerebellum (blue arrow), right frontal lobe (red arrow), and sternum (green arrow) with low, intermediate, and high tracer uptake, respectively. Photomicrographs (scale bar, 100 μm) with hematoxylin-eosin (H&E) staining (center bottom) and programmed death ligand 1 (PD-L1) immunohistochemical (IHC) staining (right bottom) show high PD-L1 expression in the sternal lesion (tumor proportion score ≥ 50%).
New immuno-PET tracer shows promise in lung cancer
August 18, 2026
Artificial intelligence (AI) assistance facilitates correct fracture identification in cases initially missed by human readers. A representative case is shown using anteroposterior radiographs in a 29-year-old male patient with wrist trauma (suspected nondisplaced transverse scaphoid fracture). The reader’s initial unaided assessment (top) resulted in a missed fracture, whereas with AI assistance (bottom), the fracture was correctly identified. The green box represents the fracture location as predicted by the AI tool, the blue box represents the reference standard annotation, and the red dots represent individual reader annotations.
AI fracture detection device validated across three European hospitals
August 18, 2026
Nominations Are Open — 2026 Minnies
Sponsored
Nominations Are Open — 2026 Minnies
August 6, 2026
Fda Button 400
FDA issues discussion paper on GenAI medical devices
August 18, 2026
More in Home
New immuno-PET tracer shows promise in lung cancer
By Will Morton
Molecular imaging can provide whole-body visualization and quantitative assessment of PD-L1 expression.
August 18, 2026
(A) Ga-68 NK224 PET/CT maximum intensity projection image (left), axial PET/CT images (center), and axial CT images (right) in a 43-year-old female participant with lung adenocarcinoma show lesions in the right cerebellum (blue arrow), right frontal lobe (red arrow), and sternum (green arrow) with low, intermediate, and high tracer uptake, respectively. Photomicrographs (scale bar, 100 μm) with hematoxylin-eosin (H&E) staining (center bottom) and programmed death ligand 1 (PD-L1) immunohistochemical (IHC) staining (right bottom) show high PD-L1 expression in the sternal lesion (tumor proportion score ≥ 50%).
AI fracture detection device validated across three European hospitals
By Will Morton
No differences in AI performance were observed across centers, and AI assistance was associated with higher reader sensitivity.
August 18, 2026
Artificial intelligence (AI) assistance facilitates correct fracture identification in cases initially missed by human readers. A representative case is shown using anteroposterior radiographs in a 29-year-old male patient with wrist trauma (suspected nondisplaced transverse scaphoid fracture). The reader’s initial unaided assessment (top) resulted in a missed fracture, whereas with AI assistance (bottom), the fracture was correctly identified. The green box represents the fracture location as predicted by the AI tool, the blue box represents the reference standard annotation, and the red dots represent individual reader annotations.
Radiology Partners unit Mosaic petitions FDA on imaging AI regulation
By AuntMinnie.com staff writers
The petition seeks clarity on the regulation of AI vision language models used for diagnostic medical image analysis.
August 18, 2026
Artificial Intelligence Ai Medical Healthcare Tools 400
FDA issues discussion paper on GenAI medical devices
By AuntMinnie.com staff writers
The paper covers risk assessment, pre-market evaluation, and considerations around foundation models and agentic AI systems.
August 18, 2026
Fda Button 400
CT for breast radiotherapy detects ischemic heart disease risk
By Will Morton
As survival after early-stage breast cancer improves, cardiovascular disease has emerged as an increasingly prominent competing risk in older women.
August 17, 2026
Heart 1
MWA may have long-term benefits for renal cell cancer patients
By Amerigo Allegretto
MWA with CT or CEUS guidance leads to "excellent" 10-year survival rates and with minimal complications.
August 17, 2026
Kidneys 400
Radiation-related cancer mortality higher for U.S. flight crew
By Amerigo Allegretto
Results point to prolonged exposure to cosmic radiation at commercial flight attitudes.
August 17, 2026
Airplane Takeoff 400
AI system cuts DEXA turnaround time, improves reports
By Will Morton
Median report creation and turnaround times dropped to under one minute.
August 14, 2026
Dexa
PAE effective in men over 80 years old
By Will Morton
Findings support PAE as an important minimally invasive treatment option for elderly patients who are nonsurgical candidates.
August 14, 2026
Prostate Imaging2
Prone positioning may benefit women undergoing PBI
By Amerigo Allegretto
Prone positioning may lead to lower heart and lung doses and lower rates of acute dermatitis.
August 14, 2026
Radiation Therapy Suite 400
Lantheus wins FDA approval for tau PET imaging agent
By AuntMinnie.com staff writers
Tauklarify, previously known as MK-6240, has been approved for tau PET imaging in adults with cognitive impairment being evaluated for Alzheimer's disease.
August 14, 2026
Approved Stamp 400
Women's Imaging MinnieCast, Episode 15: BACs and heart disease risk
By Amerigo Allegretto
Laurie Margolies, MD, shares insights on how breast arterial calcifications (BACs) on mammograms should be managed.
August 14, 2026
Minnie Cast Thumbnail (19)
Page 1 of 245
Next Page